Halobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants.

MLA

Cook-Bolden, Fran E., et al. “Halobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants.” Journal of Drugs in Dermatology : JDD, vol. 19, no. 8, Aug. 2020, pp. 747–54. EBSCOhost, https://doi.org/10.36849/JDD.2020.5250.

APA

Cook-Bolden, F. E., Hebert, A. A., Guenthner, S. T., Kang, R., Martin, G., & Jacobson, A. (2020). Halobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants. Journal of Drugs in Dermatology : JDD, 19(8), 747–754. https://doi.org/10.36849/JDD.2020.5250

Chicago

Cook-Bolden, Fran E, Adelaide A Hebert, Scott T Guenthner, Robert Kang, Gina Martin, and Abby Jacobson. 2020. “Halobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants.” Journal of Drugs in Dermatology : JDD 19 (8): 747–54. doi:10.36849/JDD.2020.5250.